A detailed history of American Wealth Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, American Wealth Advisors, LLC holds 29 shares of BIIB stock, worth $4,627. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Holding current value
$4,627
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$122.68 - $148.84 $3,557 - $4,316
29 New
29 $4.06 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track American Wealth Advisors, LLC Portfolio

Follow American Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Wealth Advisors, LLC with notifications on news.